Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
sodium chloride (MIP Pharma, 42ce96)
- Development stage
- Unknown
- Lead developer
- MIP Pharma
- Modality
- Small Molecules
- Administration
- Intranasal
01
Overview
Tetrisal is an over-the-counter (OTC) nasal spray containing sodium chloride, primarily used for nasal hygiene and the relief of nasal congestion. Distributed by the German company MIP Pharma, it is typically available as an isotonic solution (often branded as Tetrisal 400). The product works by hydrating the nasal mucosa, thinning thick mucus, and facilitating the removal of crusts, allergens, and pathogens. It is indicated for the supportive treatment of the common cold, rhinitis, and hay fever, as well as for moisturizing dry nasal passages caused by environmental factors such as heated or air-conditioned air.
- Brand names
- TetrisalTetrisal 400Tetrisal400Tetrisal-400
- Other names
- sodium chloride nasal spray
Beyond the preview
Go deeper on sodium chloride (MIP Pharma, 42ce96).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on sodium chloride (MIP Pharma, 42ce96).